Report overview
This report contains market size and forecasts of Dolutegravir and Dolutegravir Generic Drugs in global, including the following market information:
Global Dolutegravir and Dolutegravir Generic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dolutegravir and Dolutegravir Generic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dolutegravir and Dolutegravir Generic Drugs companies in 2021 (%)
The global Dolutegravir and Dolutegravir Generic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dolutegravir and Dolutegravir Generic Drugs include ViiV Healthcare Pty Ltd, Emcure Pharmaceuticals, Mylan, Aurobindo Pharma and Qilu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dolutegravir and Dolutegravir Generic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dolutegravir and Dolutegravir Generic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dolutegravir and Dolutegravir Generic Drugs Market Segment Percentages, by Type, 2021 (%)
5mg Tablets
50mg Tablets
Global Dolutegravir and Dolutegravir Generic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dolutegravir and Dolutegravir Generic Drugs Market Segment Percentages, by Application, 2021 (%)
Children
Adult
Global Dolutegravir and Dolutegravir Generic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dolutegravir and Dolutegravir Generic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dolutegravir and Dolutegravir Generic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dolutegravir and Dolutegravir Generic Drugs revenues share in global market, 2021 (%)
Key companies Dolutegravir and Dolutegravir Generic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Dolutegravir and Dolutegravir Generic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare Pty Ltd
Emcure Pharmaceuticals
Mylan
Aurobindo Pharma
Qilu Pharmaceutical
